This finding concurs with previous research that exhibited a protective effect of misoprostol on Hb levels when compared with ergometrine or placebo.14,21,22 The clinical relevance of misoprostol’s protective effect is critical, given that PPH and anaemia contribute independently and interactively to a large proportion of adverse maternal outcomes. The gene discussed is GSTM1; the disease is anemia (phenotype).